Monograph Details
|
|
Dermatological Disorders
> Skin infections (topicals)
|
|
ALTABAX |
| Manufacturer |
|
GlaxoSmithKline Pharmaceuticals |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Pleuromutilin. |
| Generic Name |
|
Retapamulin 1%; oint. |
| Indications |
|
Topical treatment of impetigo due to Staphylococcus aureus (methicillin-susceptible isolates only) or Streptococcus pyogenes in patients ≥9 months of age. |
| Adults and Children |
|
<9 months: not recommended. ≥9 months: apply thin layer to affected area (up to 100cm2 in total area in adults or 2% total body surface area in children) twice daily for 5 days. May cover with bandage or gauze dressing. Reevaluate if no improvement in symptoms within 3–4 days after starting treatment. |
| Precautions |
|
Not for intraoral, intranasal, ophthalmic, or intravaginal use. Discontinue if irritation or sensitization occurs. Prolonged use may result in superinfection. Pregnancy (Cat.B). Nursing mothers. |
| Adverse Reactions |
|
Application site irritation. |
| How Supplied |
|
Oint—5g, 10g, 15g |
| Additional Resources |
|
• Related Prescribing Note |
|
|
|
|
